Research Advocacy

Ovarian cancer survivors can shape the future of ovarian cancer research by serving as research advocates. Research advocates help funding agencies and scientists understand and prioritize the questions that are important to the ovarian cancer community. Having the input of survivors ensures that research is patient-focused and truly meets the needs of our community. Research advocates also report back to the community, sharing what they have learned, so that everyone can benefit from scientific progress.

Read reports from our research advocates

2019 Reports

2018 Reports

2017 Reports

2016 Reports

2015 Reports

2014 Reports

2013 Reports

2012 Reports

2011 Reports

Who are research advocates?

Research advocates are survivors of ovarian cancer just like you. While some of them have a background in science, most do not! They learn “on the job” and by working with more experienced advocates.  Research advocates who represent OCRA serve by invitation only.

Meet some of our current advocates

Annie Ellis

Annie Ellis was diagnosed with ovarian cancer in 2004 at the age of 40 and first got involved with the Ovarian Cancer Research Alliance in 2006. Since that time, she’s served on various committees, participated in special projects and presented her story as part of the Survivors Teaching Students: Saving Women’s Lives® program. Annie has been invited to speak at a number of national meetings about her work teaching students and as a research advocate. Annie currently volunteers with SHARE’s Ovarian Cancer Helpline and New York Presbyterian’s Woman to Woman program, and serves as a consumer peer reviewer for the Department of Defense Ovarian Cancer Research Program.

Susan Leighton

Susan Leighton works with the Ovarian Cancer Research Alliance as the National Program Director of the Survivors Teaching Students: Saving Women’s Lives® Program. Susan holds an MA in Psychology from Louisiana Tech University, is a veteran, a retired personnel management specialist and a volunteer for several community organizations. In 1997, she was diagnosed with Stage IIIC ovarian cancer and had a recurrence in 2005. Since that time, she has served on numerous panels as a research advocate – including through the Department of Defense Ovarian Cancer Research Program and the Patient Centered Outcome Research Institute. As a patient advocate she is a founding member of the Lilies of the Valley, a large ovarian cancer support and awareness group located in her hometown of Huntsville, Alabama.  Her advocacy efforts extend beyond awareness, education and research to legislation.  Susan is a member of OCRA’s Advocate Leaders program and has brought the voice of the ovarian cancer patient population to Capitol Hill on numerous occasions. In 2011, she testified before the Senate Appropriations Subcommittee on Defense in support of funding for the Department of Defense Ovarian Cancer Research Program.

Laurel PrachtLaurel Pracht is a 13+ year ovarian cancer survivor. She has a Bachelor of Science from the University of Nebraska. Laurel currently serves as a Patient Advocate with the Gynecologic Oncology Group (GOG) and a member of the Patient Advocate Advisory Board, Society of Nuclear Medicine and Molecular Imaging, where she helped create a patient friendly nuclear medicine website, She has successfully advocated to ensure that Medicare covers PET scans for women with ovarian cancer. She is a member of the Ovarian Cancer Research Alliance’s Science and Policy Advisory Committee, is the Arizona coordinator for the Survivors Teaching Students: Saving Women’s Lives® program and has been appointed to the Patient-Centered Outcomes Research Institute Patient Engagement Advisory Panel. She is president of the West Valley Ovarian Cancer Alliance, and directs a yearly charity golf tournament benefitting ovarian cancer research.

Where do research advocates serve?

Research advocates typically serve as grant reviewers within the federal agencies that fund ovarian cancer research. These include:

      • The Ovarian Cancer Research Program (OCRP) at the Department of Defense
      • The National Cancer Institute
      • The Patient Centered Outcomes Research Institute
      • The Food and Drug Administration

Advocates also serve in various capacities outside the federal government, including:

      • The NRG Oncology Cooperative Group, a nonprofit committed to promoting high quality clinical trials.
      • Institutional Review Boards (IRBs) at academic medical centers conducing ovarian cancer research

This program is supported by a grant from


Help Advance Ovarian Cancer Research

From time to time, Ovarian Cancer Research Alliance partners with other organizations on research projects that will advance our understanding of this disease. Click on the links below to learn about each research initiative.

Massachusetts General Hospital is conducting a study of long term survivors of ovarian cancer. If you were diagnosed with stage III or stage IV ovarian cancer eight or more years ago. Learn more about the study. This project is funded by the Department of Defense.

Have you or your family members been affected by breast, ovarian, prostate, melanoma, pancreatic or other related cancers that are or may be due to an inherited reason? The ABOUT Network is the first national effort to invite people from across the United States to share their experience with hereditary breast, ovarian, prostate, melanoma, pancreatic and related cancers. Continue reading more information.